Press Releases
Giving a voice to new parents during the pandemic
A new UK-wide study is looking to give a voice to people who became parents for the first time during the pandemic, in order to learn how they can be best supported.
Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of Warwick
Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the
Exercise during lockdown fell particularly for groups most at risk
A study of UK resident’s exercise patterns during the COVID-19 lockdown in March-June 2020, has found that groups that were most at risk to the adverse effects of COVID-19 were impacted the most in terms of reducing their levels of exercise. Researchers led by WMG, University of Warwick say targeted interventions are required to ensure physical and mental health impacts of sedentary behaviour do not exacerbate the risks to these groups.
Alternative to antibodies in diagnostics demonstrated in fight against viral infections such as COVID-19
Researchers at the University of Warwick, Iceni Diagnostics Ltd and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust have demonstrated their technology to detect SARS-COV-2 using sugars rather than antibodies.
Has COVID 19 undermined the rule of law? New research examines actions in the Western Balkans
The coronavirus pandemic has presented populist governments with a unique opportunity to implement authoritarian measures and to limit public scrutiny of their decisions and policies, argues Dr Andi Hoxhaj of Warwick Law School in a new paper published in the European Journal of Comparative Law and Governance.
RECOVERY-RS trial finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised COVID-19 patients
The Respiratory Strategies in COVID-19; CPAP, High-flow, and Standard Care (RECOVERY-RS) trial, co-led by the University of Warwick, has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation.